Found: 35
Select item for more details and to access through your institution.
Are our data symmetric?
- Published in:
- 2003
- By:
- Publication type:
- journal article
Impact of the COVID-19 Pandemic on Cancer Clinical Trials.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7311, doi. 10.1245/s10434-021-10406-2
- By:
- Publication type:
- Article
Understanding Verbosity: Funding Source and the Length of Consent Forms for Cancer Clinical Trials.
- Published in:
- Journal of Cancer Education, 2021, v. 36, n. 6, p. 1248, doi. 10.1007/s13187-020-01757-7
- By:
- Publication type:
- Article
Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials.
- Published in:
- Biometrics, 2011, v. 67, n. 3, p. 1047, doi. 10.1111/j.1541-0420.2011.01564.x
- By:
- Publication type:
- Article
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3251, doi. 10.3390/cancers12113251
- By:
- Publication type:
- Article
Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 2, p. 363
- By:
- Publication type:
- Article
A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 4, p. 787, doi. 10.1002/cncr.22444
- By:
- Publication type:
- Article
A prognostic model for advanced stage nonsmall cell lung cancer.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 4, p. 781, doi. 10.1002/cncr.22049
- By:
- Publication type:
- Article
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 39, doi. 10.1007/s00280-007-0443-6
- By:
- Publication type:
- Article
A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9
- By:
- Publication type:
- Article
Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 4, p. 403, doi. 10.1002/jcph.26
- By:
- Publication type:
- Article
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 16, p. 2728, doi. 10.1002/sim.5737
- By:
- Publication type:
- Article
Model-based phase I designs incorporating toxicity and efficacy for single and dual agent drug combinations: Methods and challenges.
- Published in:
- Statistics in Medicine, 2010, v. 29, n. 10, p. 1077, doi. 10.1002/sim.3706
- By:
- Publication type:
- Article
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 11, p. 2317, doi. 10.1002/sim.2707
- By:
- Publication type:
- Article
Statistical modelling of the differences between successive R-R intervals.
- Published in:
- Statistics in Medicine, 2005, v. 24, n. 3, p. 437, doi. 10.1002/sim.1948
- By:
- Publication type:
- Article
gBOIN: a unified model‐assisted phase I trial design accounting for toxicity grades, and binary or continuous end points.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 289, doi. 10.1111/rssc.12263
- By:
- Publication type:
- Article
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5358, doi. 10.1002/cncr.27528
- By:
- Publication type:
- Article
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 6, p. 1262, doi. 10.1002/cncr.25526
- By:
- Publication type:
- Article
Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple Myeloma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 3, p. 640, doi. 10.1002/cncr.24767
- By:
- Publication type:
- Article
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Prognostic Factors Differ by Tumor Stage for Small Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 12, p. 2721, doi. 10.1002/cncr.24314
- By:
- Publication type:
- Article
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 523, doi. 10.1634/theoncologist.2019-0574
- By:
- Publication type:
- Article
Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2020, v. 11, n. 6, p. 1501, doi. 10.1002/jcsm.12625
- By:
- Publication type:
- Article
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cycles.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221107242
- By:
- Publication type:
- Article
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study.
- Published in:
- Journal of Patient Experience, 2022, v. 9, p. 1, doi. 10.1177/23743735221107242
- By:
- Publication type:
- Article
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Application of multi-state models in cancer clinical trials.
- Published in:
- Clinical Trials, 2018, v. 15, n. 5, p. 489, doi. 10.1177/1740774518789098
- By:
- Publication type:
- Article
Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data.
- Published in:
- Clinical Trials, 2017, v. 14, n. 6, p. 611, doi. 10.1177/1740774517723829
- By:
- Publication type:
- Article
Daniel J. Sargent, 1970-2016.
- Published in:
- Clinical Trials, 2016, v. 13, n. 6, p. 677, doi. 10.1177/1740774516678810
- By:
- Publication type:
- Article
Statistical issues in the validation of prognostic, predictive, and surrogate biomarkers.
- Published in:
- Clinical Trials, 2013, v. 10, n. 5, p. 647, doi. 10.1177/1740774513497125
- By:
- Publication type:
- Article
The Direct Assignment Option as a Modular Design Component: An Example for the Setting of Two Predefined Subgroups.
- Published in:
- Computational & Mathematical Methods in Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/210817
- By:
- Publication type:
- Article